FDA Approval of Zongertinib in HER2-Mutated NSCLC
FDA Approval of Zongertinib in HER2-Mutated NSCLC

Joshua Sabari, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

FDA Approves Dato-DXd for Patients With EGFR-Mutated NSCLC
FDA Approves Dato-DXd for Patients With EGFR-Mutated NSCLC

Jacob Sands, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD